IP Library Granted Patent US 7,654,969
Granted Patent B2
US 7,654,969 · App. 12/026,190 · Granted Feb 2, 2010

Integrated spot monitoring device with fluid sensor

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,654,969
App. No.
12/026,190
Granted
Feb 2, 2010
Kind
B2
Abstract

A bodily fluid sampling device is operable to breach the skin surface and allow bodily fluid to emerge from the breach location. The bodily fluid sampling device further evaluates the amount of bodily fluid emerged from breach location and determines whether the amount is sufficient or insufficient for a particular purpose, such as sampling and testing. The determination is accomplished automatically without moving the device. The user may also intervene to perform a variety of tasks following the determination of the amount of bodily fluid.

Claims (24)

1. A body fluid sampling device, comprising:

a meter;

a lancing device configured to create an incision in a surface of tissue, wherein the lancing device includes a lancet;

a fluid detector configured to detect sufficiency of body fluid bled from the incision while on the surface of the tissue;

an analysis device configured to analyze the body fluid once the fluid detector detects that the body fluid on the surface of the tissue is sufficient for analysis, wherein the analysis device includes a test strip;

an integrated lancing test strip including the lancet attached to the test strip;

the integrated lancing test strip being detachably coupled to the meter, the lancet and test strip of the integrated lancing test strip being configured to be removed together from the meter as a single unit;

wherein the fluid detector includes one or more sensors disposed on the integrated lancing test strip to detect sufficiency of the body fluid bled from the incision while on the surface of the tissue;

the meter including a housing in which the fluid detector is disposed, the housing defining a cavity with an opening where the incision is created; and

wherein the fluid detector includes an ultrasonic detector configured to detect a change in resonance of the cavity in the housing as the body fluid from the incision fills the cavity.

2. The body fluid sampling device of claim 1 , further comprising:

a controller operatively coupled to the lancing device and a firing mechanism; and

an output device operatively coupled to the controller, wherein the output device is configured to positively indicate insufficiency of the body fluid when the fluid detector detects the insufficiency of the body fluid.

3. The body fluid sampling device of claim 1 , wherein:

the test strip defines a capillary channel with a capillary channel opening for drawing the body fluid; and

the one or more sensors are disposed proximal the capillary channel opening for locating the capillary channel opening during drawing of the body fluid.

4. The body fluid sampling device of claim 1 , wherein the analysis device includes a test strip with a capillary channel for drawing the body fluid and an actuator coupled to the test strip for positioning the capillary channel to collect the body fluid when the fluid detector detects a sufficient amount of the body fluid on the surface of the tissue.

5. The device of claim 1 , further comprising:

a controller;

an expression device operatively coupled to the fluid detector through the controller; and

the controller being configured to activate the expression device to automatically express the body fluid from the incision upon detecting with the fluid detector that the body fluid on the surface of the tissue is insufficient for analysis.

6. The body fluid sampling device of claim 5 , further comprising:

the housing having a skin contacting portion around the opening that contacts the tissue during creation of the incision; and

wherein the expression device is configured to express the body fluid without requiring removal of the skin contacting portion of the housing from the tissue.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 23, 2015
From: ROCHE DIAGNOSTICS OPERATIONS, INC.
To: ROCHE DIABETES CARE, INC.
Reel/Frame 036008/0670 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 5, 2008
From: WONG, DANIEL; WIEGEL, CHRISTOPHER D.
To: ROCHE DIAGNOSTICS OPERATIONS, INC.
Reel/Frame 020466/0811 →